Skip to content
Chaussée d’Etterbeek 180, 1040 – Brussels
[email protected]
ABOUT US
Values
Vision & Mission
Objectives
Structure
Steering Committee
Constitution
5A’s of Access
Funding
PARTNERS
Definition of ′Partners′
List of Partners
Contributors
MEP INTEREST GROUP
About
Objectives
Co-Chair MEP
Supporting MEP
Еvents
Initiatives
Conferences
Roundtables
Model Access Solutions
About
Advisory Board
Why to apply?
Submission portal
Frequently Asked Questions
News
Press Room
Our Model Access Solutions
Library
News
CONTACTS
VEIKALS
PACT
ABOUT US
Values
Vision & Mission
Objectives
Structure
Steering Committee
Constitution
5A’s of Access
Funding
PARTNERS
Definition of ′Partners′
List of Partners
Contributors
MEP INTEREST GROUP
About
Objectives
Co-Chair MEP
Supporting MEP
Еvents
Initiatives
Conferences
Roundtables
Model Access Solutions
About
Advisory Board
Why to apply?
Submission portal
Frequently Asked Questions
News
Press Room
Our Model Access Solutions
Library
News
CONTACTS
Alviina ALAMETSÄ
March 12, 2021
Post navigation
Previous post
Helmut SCHOLZ
Post navigation
Next post
Milan ZVER
Recent Posts
The Pharmaceutical Strategy for Europe: To ensure access to innovations for patients now and in the future
Opening webinar of the series “The Future of Health: Time to Act”
Registrations are now open – Time to Act!
CSR-based performance and meaningful stakeholder involvement: the key to improving access through the Recovery and Resilience Facility
PACT launches open call for best practice examples in access to healthcare
Turning principles into a reality – for more equitable healthcare across Europe
Calendar
August 2022
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Follow us on Twitter
My Tweets
